# International PFO Consortium

> **NCT00859885** · — · UNKNOWN · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 1500 (estimated)

## Conditions studied

- Stroke
- Transient Ischemic Attack

## Interventions

- **DRUG:** Antithrombotic treatment
- **DEVICE:** percutaneous device closure of PFO

## Key facts

- **NCT ID:** NCT00859885
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09-08
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2017-12-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00859885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00859885, "International PFO Consortium". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00859885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*